N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine

C99H93F15N30 — CID 158778025

IUPACN-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine
SMILESCC(C)Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2CCCC3)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2CCCC3)n[nH]1.FC(F)(F)c1ccccc1-c1nc2c(c(Nc3n[nH]c(-c4ccccc4)n3)n1)CCCC2.FC(F)(F)c1ccccc1-c1nc2c(c(Nc3n[nH]c(C4CC4)n3)n1)CCCC2.FC(F)(F)c1ccccc1-c1nc2c(c(Nc3ncn[nH]3)n1)CCCC2
InChIInChI=1S/C23H19F3N6.C21H23F3N6.C20H19F3N6.C18H17F3N6.C17H15F3N6/c24-23(25,26)17-12-6-4-10-15(17)20-27-18-13-7-5-11-16(18)21(28-20)30-22-29-19(31-32-22)14-8-2-1-3-9-14;1-12(2)11-17-26-20(30-29-17)28-19-14-8-4-6-10-16(14)25-18(27-19)13-7-3-5-9-15(13)21(22,23)24;21-20(22,23)14-7-3-1-5-12(14)17-24-15-8-4-2-6-13(15)18(25-17)27-19-26-16(28-29-19)11-9-10-11;1-10-22-17(27-26-10)25-16-12-7-3-5-9-14(12)23-15(24-16)11-6-2-4-8-13(11)18(19,20)21;18-17(19,20)12-7-3-1-5-10(12)14-23-13-8-4-2-6-11(13)15(24-14)25-16-21-9-22-26-16/h1-4,6,8-10,12H,5,7,11,13H2,(H2,27,28,29,30,31,32);3,5,7,9,12H,4,6,8,10-11H2,1-2H3,(H2,25,26,27,28,29,30);1,3,5,7,11H,2,4,6,8-10H2,(H2,24,25,26,27,28,29);2,4,6,8H,3,5,7,9H2,1H3,(H2,22,23,24,25,26,27);1,3,5,7,9H,2,4,6,8H2,(H2,21,22,23,24,25,26)
InChIKeyIQSJAXKRRVKMCV-UHFFFAOYSA-N
MW1988.01 g/mol
LogP23.57
Rot. Bonds19

About N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine

N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine (PubChem CID 158778025) has the molecular formula C99H93F15N30 and a molecular weight of 1988.01 g/mol. Its IUPAC name is N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine.

Molecular Properties

Compound NameN-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine
PubChem CID158778025
Molecular FormulaC99H93F15N30
Molecular Weight1988.01 g/mol
Exact Mass1986.80
IUPAC NameN-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine
SMILESCC(C)Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2CCCC3)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2CCCC3)n[nH]1.FC(F)(F)c1ccccc1-c1nc2c(c(Nc3n[nH]c(-c4ccccc4)n3)n1)CCCC2.FC(F)(F)c1ccccc1-c1nc2c(c(Nc3n[nH]c(C4CC4)n3)n1)CCCC2.FC(F)(F)c1ccccc1-c1nc2c(c(Nc3ncn[nH]3)n1)CCCC2
InChIInChI=1S/C23H19F3N6.C21H23F3N6.C20H19F3N6.C18H17F3N6.C17H15F3N6/c24-23(25,26)17-12-6-4-10-15(17)20-27-18-13-7-5-11-16(18)21(28-20)30-22-29-19(31-32-22)14-8-2-1-3-9-14;1-12(2)11-17-26-20(30-29-17)28-19-14-8-4-6-10-16(14)25-18(27-19)13-7-3-5-9-15(13)21(22,23)24;21-20(22,23)14-7-3-1-5-12(14)17-24-15-8-4-2-6-13(15)18(25-17)27-19-26-16(28-29-19)11-9-10-11;1-10-22-17(27-26-10)25-16-12-7-3-5-9-14(12)23-15(24-16)11-6-2-4-8-13(11)18(19,20)21;18-17(19,20)12-7-3-1-5-10(12)14-23-13-8-4-2-6-11(13)15(24-14)25-16-21-9-22-26-16/h1-4,6,8-10,12H,5,7,11,13H2,(H2,27,28,29,30,31,32);3,5,7,9,12H,4,6,8,10-11H2,1-2H3,(H2,25,26,27,28,29,30);1,3,5,7,11H,2,4,6,8-10H2,(H2,24,25,26,27,28,29);2,4,6,8H,3,5,7,9H2,1H3,(H2,22,23,24,25,26,27);1,3,5,7,9H,2,4,6,8H2,(H2,21,22,23,24,25,26)
InChIKeyIQSJAXKRRVKMCV-UHFFFAOYSA-N
XLogP23.57
TPSA396.90 Ų
H-Bond Donors10
H-Bond Acceptors25
Rotatable Bonds19
Heavy Atoms144
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001988.01
LogP ≤ 523.57
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1025

Analyze N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine?
The IUPAC name of N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine (CID 158778025) is N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine.
What is the SMILES notation for N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine?
The canonical SMILES for N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine is CC(C)Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2CCCC3)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2CCCC3)n[nH]1.FC(F)(F)c1ccccc1-c1nc2c(c(Nc3n[nH]c(-c4ccccc4)n3)n1)CCCC2.FC(F)(F)c1ccccc1-c1nc2c(c(Nc3n[nH]c(C4CC4)n3)n1)CCCC2.FC(F)(F)c1ccccc1-c1nc2c(c(Nc3ncn[nH]3)n1)CCCC2.
What is the InChIKey of N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine?
The InChIKey is IQSJAXKRRVKMCV-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H19F3N6.C21H23F3N6.C20H19F3N6.C18H17F3N6.C17H15F3N6/c24-23(25,26)17-12-6-4-10-15(17)20-27-18-13-7-5-11-16(18)21(28-20)30-22-29-19(31-32-22)14-8-2-1-3-9-14;1-12(2)11-17-26-20(30-29-17)28-19-14-8-4-6-10-16(14)25-18(27-19)13-7-3-5-9-15(13)21(22,23)24;21-20(22,23)14-7-3-1-5-12(14)17-24-15-8-4-2-6-13(15)18(25-17)27-19-26-16(28-29-19)11-9-10-11;1-10-22-17(27-26-10)25-16-12-7-3-5-9-14(12)23-15(24-16)11-6-2-4-8-13(11)18(19,20)21;18-17(19,20)12-7-3-1-5-10(12)14-23-13-8-4-2-6-11(13)15(24-14)25-16-21-9-22-26-16/h1-4,6,8-10,12H,5,7,11,13H2,(H2,27,28,29,30,31,32);3,5,7,9,12H,4,6,8,10-11H2,1-2H3,(H2,25,26,27,28,29,30);1,3,5,7,11H,2,4,6,8-10H2,(H2,24,25,26,27,28,29);2,4,6,8H,3,5,7,9H2,1H3,(H2,22,23,24,25,26,27);1,3,5,7,9H,2,4,6,8H2,(H2,21,22,23,24,25,26).
What are the key properties of N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine?
N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine has a molecular weight of 1988.01 g/mol, XLogP of 23.57, 19 rotatable bonds, 10 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-cyclopropyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(5-phenyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine;N-(1H-1,2,4-triazol-5-yl)-2-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroquinazolin-4-amine is sourced from PubChem (CID 158778025), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).